Louis Lehot on OpenAI Corporate Overhaul – 'Who will be the guardrails to the public good?'
27 September 2024
Pitchbook
Foley & Lardner LLP partner Louis Lehot commented on leadership and structural changes at OpenAI in the Pitchbook article, “Altman’s corporate overhaul could boost OpenAI’s growth—at a cost.”
Of OpenAI’s reported plans to remove its longstanding profit cap on investor returns, Lehot said, “[Removing the profit cap is] a huge boon for the investors.”
With OpenAI’s transition from nonprofit to public benefit corporation raising questions, Lehot asked, “Who will be the guardrails to the public good?”
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."